Literature DB >> 4019049

Neuropsychological and electrophysiological examination of a patient with Wilson's disease.

R A Bornstein, D R McLean, K Ho.   

Abstract

A patient with Wilson's disease underwent neuropsychological and electrophysiological examination 4 months following symptom onset. Although motor deficits were more severe, there was considerable impairment of cognitive and intellectual function. Auditory evoked responses were also abnormal in this patient. This case is unusual because of the early severe cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019049     DOI: 10.3109/00207458508985620

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

1.  Expression profiling of p53-target genes in copper-mediated neuronal apoptosis.

Authors:  Jacob W Vanlandingham; Nadine M Tassabehji; Rikki C Somers; Cathy W Levenson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.

Authors:  H Hefter; T Kuwert; H Herzog; G Arendt; W Stremmel; L E Feinendegen
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

Review 3.  Cognitive deficits related to major organ failure: the potential role of neuropsychological testing.

Authors:  M E Farmer
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

4.  Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders.

Authors:  Mg Carta; G Mura; O Sorbello; G Farina; L Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-09-18

5.  Bipolar disorders and Wilson's disease.

Authors:  Mauro Giovanni Carta; Orazio Sorbello; Maria Francesca Moro; Krishna M Bhat; Enrico Demelia; Alessandra Serra; Gioia Mura; Federica Sancassiani; Mario Piga; Luigi Demelia
Journal:  BMC Psychiatry       Date:  2012-05-30       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.